Close

Cassava Sciences Reports First Quarter 2021 Financial Results and Announces Guidance on Clinical Data Release

Go back to Cassava Sciences Reports First Quarter 2021 Financial Results and Announces Guidance on Clinical Data Release
(NASDAQ: SAVA) Delayed: 21.63 +0.89 (4.29%)
Previous Close $20.74    52 Week High
Open $20.58    52 Week Low
Day High $21.88    P/E N/A 
Day Low $20.43    EPS
Volume 530,350